New Healthcare Law Could Provide Confusion, Not Clarity on Costs
For many of us, the new year is a time for rebirth, reawakening, or an optimal time to enact change. Whether you decide to commit to those new habits remains to be seen, but one change that’s legally mandated to stick is taking place in hospitals around the country.
After Her Skiing Accident, An Uphill Battle Over Snowballing Bills
By Jordan Rau for Kaiser Health News Sarah Witter couldn’t get a break even though her leg had gotten several. As she lay on a ski trail in Vermont last February, Witter, now 63, knew she hadn’t suffered a regular fall because she could not get up. An X-ray showed she had fractured two major bones in her lower left leg.
‘We’re Fighting For Our Lives’: Patients Protest Sky-High Insulin Prices
By Bram Sable-Smith for Kaiser Health News Angela Lautner knew her thirst was unusual, even for someone directing airplanes, outside in the Memphis summer heat. “We had coolers of Gatorade and water for people to always have access to,” Lautner recalled of her job as a ground services agent. “But the amount of thirst that I felt was just incredible.” She had no appetite and she lost an unusual amount of weight. Then after a trip to the emergency room, Lautner, who was 22, was diagnosed with Type 1 diabetes. The diagnosis was life-changing.
Pfizer Increased Prices for 41 of Their Drugs and Buried the News in a Friday News Dump
The Campaign for Sustainable Rx Pricing (CSRxP) recently released a statement shedding light on Pfizer’s decision to increase the price of 41 drugs come January and bury the news: “Pfizer can try to bury the announcement of 41 drug price hikes in a Friday news dump—but it can’t hide the real-world impact on millions of patients who are about to see the price of their medications go up. Right before the holiday season, hardworking families will now be forced to re-evaluate budgets for next year.”
Severe Allergy Sufferers Rejoice: 16% Cheaper EpiPen Called Symjepi Launching in 2019
Sandoz, a generic drugmaker, and Adamis Pharmaceuticals have announced their joint plan to roll out a generic version of the commonly prescribed and well-known EpiPen come early 2019. Sandoz’s generic epinephrine injector will be known as Symjepi and will be priced so as to be cheaper and relatively more affordable than EpiPens.
Cancerous Growth: When Oncology Drug Prices Keep Increasing, Only Big Pharma Wins
In North Carolina, there were an estimated 55,130 new cases of cancer in 2018 alone. The estimated number of deaths is 20,380. The rest of the U.S. saw 1,735,350 new cancer cases this year, with an estimated $147 billion of the healthcare necessary for treatment going towards just oncology drugs alone.